As HSD11B2 provides the substrates for HSD11B1 and higher levels of HSD11B2 activity have been described in the kidney compared to other tissues,14 we hypothesized that the inhibition of HSD11B1 could be more impactful in an orthotopic model of renal cancer. The gene discussed is HSD11B1; the disease is renal carcinoma.